PBQAX
Price
$23.85
Change
-$0.32 (-1.32%)
Updated
Jun 13 closing price
Net Assets
1.02B
RGAGX
Price
$78.43
Change
-$0.94 (-1.18%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

PBQAX vs RGAGX

Header iconPBQAX vs RGAGX Comparison
Open Charts PBQAX vs RGAGXBanner chart's image
PGIM Jennison Blend A
Price$23.85
Change-$0.32 (-1.32%)
VolumeN/A
Net Assets1.02B
American Funds Growth Fund of Amer R6
Price$78.43
Change-$0.94 (-1.18%)
VolumeN/A
Net Assets306.22B
PBQAX vs RGAGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PBQAX vs. RGAGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBQAX is a Buy and RGAGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 306B vs. PBQAX (1.02B). RGAGX pays higher dividends than PBQAX: RGAGX (0.65) vs PBQAX (0.47). PBQAX was incepted earlier than RGAGX: PBQAX (35 years) vs RGAGX (16 years). PBQAX (0.93) is less costly to investors than RGAGX (0.30). PBQAX is a more actively managed with annual turnover of: 47.00 vs. RGAGX (25.00). RGAGX has a lower initial minimum investment than PBQAX: RGAGX (250) vs PBQAX (1000). RGAGX annual gain was more profitable for investors over the last year : 7.67 vs. PBQAX (-3.21). RGAGX return over 5 years is better than : 51.11 vs. PBQAX (26.34).
PBQAXRGAGXPBQAX / RGAGX
Total Expense Ratio0.930.30310%
Annual Report Gross Expense Ratio0.930.30310%
Fund Existence35 years16 years-
Gain YTD-1.3655.205-26%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B306B0%
Annual Yield % from dividends0.470.6572%
Returns for 1 year-3.217.67-42%
Returns for 3 years34.9354.6664%
Returns for 5 years26.3451.1152%
Returns for 10 years10.5375.6214%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBIX124.39-0.62
-0.50%
Neurocrine Biosciences
NMIH40.34-0.26
-0.64%
NMI Holdings
PMCB1.01-0.01
-0.99%
PharmaCyte Biotech
GSBC55.62-1.83
-3.19%
Great Southern Bancorp
CXDO5.14-0.36
-6.55%
Crexendo